drugset / Trial / NCT01576003
Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Completed
10 enrolled
Children's Hospital Medical Center, Cincinnati
Emmaus Medical, Inc. · collabEmory University · collabNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collabUniversity of Colorado, Denver · collabUniversity of Michigan · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this research study is to evaluate the effects (good and bad) of supplementation with Glutamine to that of a placebo (L-alanine), on your child and their Short Bowel Syndrome. Researchers are doing this study to see if the addition of Glutamine to oral/tube feeding (nutrition therapy) will work better by preventing bloodstream infections, improving growth, and/or changing the make-up of bacteria in your child's intestine. Glutamine is approved by the FDA for use in adults with Short Bowel Syndrome. In this study, the investigators will be assessing how well Glutamine affects Short Bowel Syndrome in children.
Timeline
- Start
- 2012-04
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glutamine | Other / unclassified | 0.3 g/kg | Oral |